QL
OCUL icon

Quarry LP’s Ocular Therapeutix OCUL Stock Holding History

Quarry LP’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.8K Buy
+3,238
New +$29.4K ﹤0.01% 757
2025
Q4 		– Sell
-6,870
Closed -$80.3K – 2476
2025
Q3 		$80.3K Buy
+6,870
New +$82.2K 0.02% 595

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quarry LP's OCUL Position: Q2 2026 in Review

Quarry LP opened a new position in Ocular Therapeutix (OCUL) in Q2 2026: 3,238 shares worth $31.8K. The stake represents ﹤0.01% of the portfolio and ranks #757 among its holdings. This is a return to the name: Quarry LP previously reported a position in OCUL as recently as Q3 2025.

Quarry LP first reported a position in OCUL in Q3 2025 and has held it in 2 quarters since. The position peaked at $80.3K in Q3 2025. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Quarry LP held 3,238 shares of Ocular Therapeutix worth $31.8K as of Q2 2026.
  • Ocular Therapeutix was a new Quarry LP position in Q2 2026.
  • Ocular Therapeutix made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #757 holding.
  • Quarry LP first reported a position in Ocular Therapeutix in Q3 2025 and has held it in 2 quarters since.
  • Quarry LP's Ocular Therapeutix position peaked at $80.3K in Q3 2025.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.